Cannabix Technologies Inc., a company operating within the Information Technology sector, specifically in the Electronic Equipment, Instruments & Components industry, has been making significant strides in the development of marijuana breathalyzers. These devices are designed for use by law enforcement and workplaces across North America, addressing the growing need for reliable tools to measure impairment due to cannabis consumption.
As of May 28, 2026, Cannabix Technologies Inc. is listed on the Canadian National Stock Exchange, with its shares trading at a close price of CAD 0.64. The company’s stock has experienced fluctuations over the past year, reaching a 52-week high of CAD 0.95 on March 18, 2026, and a low of CAD 0.455 on September 15, 2025. The market capitalization of Cannabix Technologies Inc. stands at CAD 74,776,304, reflecting its current valuation in the market.
Cannabix Technologies Inc. has positioned itself as a leader in the niche market of cannabis impairment detection. The company’s focus on developing advanced breathalyzers is particularly relevant in the context of evolving cannabis legislation across North America, where the legal status of cannabis has been changing, necessitating new tools for enforcement and workplace safety.
The company’s efforts are aimed at providing law enforcement agencies and employers with reliable and efficient solutions to ensure public safety and compliance with regulations. By leveraging cutting-edge technology, Cannabix Technologies Inc. aims to enhance the accuracy and usability of its products, thereby supporting the broader adoption of these devices in various sectors.
As the demand for such technology continues to grow, Cannabix Technologies Inc. is likely to play a crucial role in shaping the landscape of cannabis impairment detection. The company’s ongoing research and development efforts are expected to drive innovation in this field, potentially leading to new product offerings and expanded market opportunities.
In summary, Cannabix Technologies Inc. is at the forefront of developing marijuana breathalyzers, a critical tool for law enforcement and workplace safety in the context of increasing cannabis legalization. With a solid market presence and a clear focus on innovation, the company is well-positioned to capitalize on the growing demand for reliable impairment detection solutions.
